UnitedHealth Group Incorporated (NYSE:UNH) is Penn Davis Mcfarland Inc.'s 8th Largest Position

Penn Davis Mcfarland Inc. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 70,685 shares of the healthcare conglomerate's stock after acquiring an additional 3,138 shares during the quarter. UnitedHealth Group accounts for about 4.4% of Penn Davis Mcfarland Inc.'s investment portfolio, making the stock its 8th largest holding. Penn Davis Mcfarland Inc.'s holdings in UnitedHealth Group were worth $37,021,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of UNH. Norges Bank purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $6,375,744,000. GAMMA Investing LLC lifted its stake in UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares during the period. Raymond James Financial Inc. purchased a new position in UnitedHealth Group during the 4th quarter valued at $1,914,740,000. Amundi lifted its position in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after buying an additional 2,301,010 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer now directly owns 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Wells Fargo & Company reissued an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. UBS Group reduced their target price on shares of UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating on the stock in a research report on Wednesday. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their price target for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. Finally, JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a research note on Friday, June 20th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $415.57.

UnitedHealth Group Stock Performance

Shares of UNH traded up $0.41 during trading hours on Thursday, hitting $302.43. The stock had a trading volume of 6,497,799 shares, compared to its average volume of 7,399,648. The firm has a market capitalization of $274.35 billion, a PE ratio of 12.66, a PEG ratio of 1.45 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a fifty day moving average price of $342.22 and a 200 day moving average price of $458.07. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the previous year, the business posted $6.91 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a $2.21 dividend. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.92%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.